India Pesticides Limited has informed the Exchange about Transcript
IPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
India Pesticides Limited (IPL) reported FY25 revenue of INR 844 crore, up 21% year-on-year, with EBITDA of INR 134 crore (up 32%) at a 16% margin and net profit of INR 82 crore (up 37%). Q4 FY25 was particularly strong with revenue of INR 211 crore (up 62% YoY) and EBITDA up 373% as Chinese destocking tapered and agrochemical demand stabilized. For FY26, management guided revenue of around INR 1,000 crore and EBITDA margin expansion to 18%–20%, driven by operating leverage, new product additions, and backward integration. The company plans a capex of INR 116 crore in FY26 (INR 200 crore over two years) while staying debt-free. Key herbicide Pretilachlor is being scaled to 8,500-tonne capacity by August 2025 with potential revenue exceeding INR 300 crore. New product registrations were secured in the EU (4), the US (2), and Australia (2 formulations), with commercial supplies to the US and Japan already underway.
This is a constructive earnings call for shareholders, with strong FY25 results and confident FY26 guidance on both revenue (~19% growth) and margin expansion (200–400 bps). The combination of debt-free status, capacity-led growth, Pretilachlor scaling, and traction in regulated markets points to a positive business outlook, though margin guidance to the earlier 25% level remains an open multi-year goal.